BlackRock Fund Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$51.8M	Buy	2,309,648 +251,317	+12%	+$4.91M	0.01%	1664
2016 Q3	$46.7M	Buy	2,058,331 +109,789	+6%	+$2.58M	0.01%	1625
2016 Q2	$46M	Sell	1,948,542 -36,578	-2%	-$903K	0.01%	1554
2016 Q1	$40.5M	Buy	1,985,120 +82,609	+4%	+$2.62M	0.01%	1578
2015 Q4	$97.9M	Buy	1,902,511 +130	+0%	+$6.3K	0.02%	981
2015 Q3	$81.1M	Buy	1,902,381 +104,668	+6%	+$5.05M	0.02%	1061
2015 Q2	$81.9M	Sell	1,797,713 -2,901	-0.2%	-$117K	0.02%	1159
2015 Q1	$68.4M	Buy	1,800,614 +125,966	+8%	+$4.33M	0.02%	1288
2014 Q4	$47.4M	Buy	1,674,648 +376,728	+29%	+$10.5M	0.01%	1498
2014 Q3	$32.8M	Sell	1,297,920 -1,403	-0.1%	-$37K	0.01%	1638
2014 Q2	$37.9M	Buy	1,299,323 +543,086	+72%	+$13.1M	0.01%	1589
2014 Q1	$19.6M	Buy	756,237 +32,278	+4%	+$861K	0.01%	2007
2013 Q4	$18.6M	Buy	723,959 +474,878	+191%	+$11.5M	0.01%	2028
2013 Q3	$6.66M	Buy	249,081 +29,713	+14%	+$707K	﹤0.01%	2602
2013 Q2	$5.39M	Buy	+219,368	New	+$4.36M	﹤0.01%	2640